Kitov Pharma Updates on Motions in USA Initiated by Kitov Chairman
18 sept. 2018 12h57 HE
|
Kitov Pharma Ltd.
Tel Aviv, Israel, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that, following a filing by Kitov’s Chairman of...
Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results
29 août 2018 08h00 HE
|
Kitov Pharma Ltd.
Tel Aviv, Israel, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results...
Kitov Announces Settlement of Shareholder Class Action Litigation
30 juil. 2018 07h47 HE
|
Kitov Pharma Ltd.
Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has entered into a Stipulation...
Kitov to Host Business Update Conference Call on Monday, July 2
27 juin 2018 09h17 HE
|
Kitov Pharma Ltd.
Tel Aviv, Israel, June 27, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV), an innovative biopharmaceutical company, today announced that it will host a business update...
Kitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy
15 juin 2018 09h31 HE
|
Kitov Pharma Ltd.
Results in PDX model of pancreatic cancer supports planned IND for NT219 Completes acquisition of substantially all minority shares of TyrNovo, June 15, 2018 TEL AVIV, Israel, June 15, 2018 ...
Kitov Announces Pricing of $8,150,000 Registered Direct Offering
01 juin 2018 08h40 HE
|
Kitov Pharma Ltd.
TEL-AVIV, Israel, June 01, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that it has entered into definitive agreements...
FDA Approves Kitov’s Consensi™ for Treatment of Osteoarthritis Pain and Hypertension
31 mai 2018 13h45 HE
|
Kitov Pharma Ltd.
New drug choice for millions of Americans offers one pill for treatment of osteoarthritis pain with a built-in antihypertensive TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) -- Kitov...
Kitov Announces Consensi™ Commercialization Agreement for China
11 mai 2018 08h30 HE
|
Kitov Pharma Ltd.
Consensi™ PDUFA date of May 31, 2018, Upcoming TEL AVIV, Israel, May 11, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced...